Panacea Biotec Limited (PANACEABIO.NS)
NSE - NSE Real-time price. Currency in INR
Add to watchlist
As of 02:27PM IST. Market open.
Currency in INR
Valuation measures4
| Market cap (intra-day) | 7.28B |
| Enterprise value | 5.64B |
| Trailing P/E | 0.61 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 1.31 |
| Price/book (mrq) | 0.87 |
| Enterprise value/revenue | 1.01 |
| Enterprise value/EBITDA | 13.51 |
Trading information
Stock price history
| Beta (5Y monthly) | N/A |
| 52-week change 3 | -2.62% |
| S&P500 52-week change 3 | 23.99% |
| 52-week high 3 | 202.50 |
| 52-week low 3 | 112.35 |
| 50-day moving average 3 | 136.65 |
| 200-day moving average 3 | 153.02 |
Share statistics
| Avg vol (3-month) 3 | 152.47k |
| Avg vol (10-day) 3 | 114.33k |
| Shares outstanding 5 | 61.25M |
| Implied shares outstanding 6 | 66.7M |
| Float 8 | 15.63M |
| % held by insiders 1 | 73.76% |
| % held by institutions 1 | 0.00% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 19 Sept 2011 |
| Last split factor 2 | 10:1 |
| Last split date 3 | 03 Feb 2003 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Mar 2024 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | -0.20% |
| Operating margin (ttm) | -2.74% |
Management effectiveness
| Return on assets (ttm) | -1.54% |
| Return on equity (ttm) | -0.18% |
Income statement
| Revenue (ttm) | 5.85B |
| Revenue per share (ttm) | 95.00 |
| Quarterly revenue growth (yoy) | 14.20% |
| Gross profit (ttm) | N/A |
| EBITDA | 57.4M |
| Net income avi to common (ttm) | -11.7M |
| Diluted EPS (ttm) | -0.19 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 1.8B |
| Total cash per share (mrq) | 28.92 |
| Total debt (mrq) | 209.9M |
| Total debt/equity (mrq) | 2.50% |
| Current ratio (mrq) | 1.57 |
| Book value per share (mrq) | 135.43 |
Cash flow statement
| Operating cash flow (ttm) | -1M |
| Levered free cash flow (ttm) | -356.09M |
© 2024 Yahoo. All rights reserved.